Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals

Industrial Health

Volumn 38, Issue 2, 2000, Pages 143-152

  Nakajima, Tamie ^a   Aoyama, Toshifumi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acquired factors; Aldehyde dehydrogenase 2; Biological monitoring; Cytochrome P450; Glutathione S transferase; N acetyltransferase 2; Polymorphism; Susceptibility to disease

Indexed keywords

ACYLTRANSFERASE; ALDEHYDE DEHYDROGENASE; CYTOCHROME P450; DRUG METABOLIZING ENZYME; GLUTATHIONE TRANSFERASE; INDUSTRIAL CHEMICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE);

BIOLOGICAL MONITORING; CARCINOGENICITY; CHEMICAL INJURY; DISEASE PREDISPOSITION; DRUG METABOLISM; ENZYME POLYMORPHISM; GENETIC RISK; HUMAN; OCCUPATIONAL HAZARD; REVIEW;

EID: 0034061176     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.38.143     Document Type: Review

References (67)

1. Sato A, Nakajima T (1987) Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scand J Work Environ Health 13, 81-93.
2. Gonzalez FJ (1990) Hereditary polymorphisms of human drug-metabolizing enzymes and cancer susceptibility. Birth Defects 26, 17-42.
3. Nakajima T, Wang RS, Murayama N (1993) Immunochemical assessment of the influence of nutritional, physiological and environmental factors on the metabolism of toluene. Int Arch Environ Occup Health 65, S127-30.
4. Nakajima T (1997) Cytochrome P450 isoforms and the metabolism of volatile hydrocarbons of low relative molecular mass. J Occup Health 39, 83-91.
5. Nakajima T, Wang RS (1994) Induction of cytochrome P450 by toluene. Int J Biochem 26, 1333-40.
6. Environmental Health Criteria 155 Biomarkers and Risk Assessment: Concepts and Principles. WHO Geneva, 1993.
7. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphism of the cytochrome P4501A1 gene. FEBS Lett 263, 131-3.
8. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, Vainio H (1992) Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidem. Biomarkers Prev 1, 485-9.
9. Zhang ZY, Fasco MJ, Huang L, Guengerich FP, Kaminsky LS (1996) Characterization of purified human recombinant cytochrome P4501A1-Ile462 and -Va1462: assessment of a role for the rare allele in carcinogenesis. Cancer Res 56, 3926-33.
10. Nakajima T, Elovaara E, Anttila S, Hirvonen A, Camus A-M, Hayes JD, Ketterer B, Vainio H (1995) Expression of polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis 16, 707-11.
11. Taioli E, Trachman J, Chen X, Toniolo P, Garte, SJ (1995) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55, 3757-8.
12. Yamazaki H, Inui Y, Yun CH, Guengerich JF, Shimada T (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789-94.
13. Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-flanking region changes transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110, 559-65.
14. Tsutsumi M, Takada A, Wang JS (1994) Genetic polymorphisms of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology 107, 1430-5.
15. Tsutsumi M, Wang JS, Takase S, Takada A (1994) Hepatic messenger RNA contents of cytochrome P4502E1 in patients with different P4502E1 genotypes. Alcohol Alcohol 29 (Suppl), 29-32.
16. Maezawa Y, Yamauchi M, Toda G (1994) Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to alcoholic liver cirrhosis. Am J Gastroenterology 89, 561-5.
17. Uematsu F, Ikawa S, Kikuchi H, Sagami I, Kanamaru R, Abe T, Satoh K, Motomiya M, Watanabe M (1994) Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics 4, 58-63.
18. Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL, Spitz MR (1997) Association between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18, 967-73.
19. NakajimaT, Elovaara E, Park SS, Gelboin HV, Hietanen E, Vainio H (1989) Immunochemical characterization of cytochrome P-450 isozymes responsible for benzene oxidation in the rat liver. Carcinogenesis 9, 1713-7.
20. Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, Li GL, Dosemeci M, Linet M, Zhang L, Xi L, Wacholder S, Lu W, Meyer KB, Titenko-Holland N, Yin S, Ross D (1997) Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorozoxazone. Cancer Res. 57, 2839-42.
21. Meyer UA, Skoda RC, Zanger UM (1990) The genetic polymorphism of debrisoquine/sparteine metabolism - molecular mechanisms. Pharmacol Ther 46, 297-308.
22. Bellec G, Dreano Y, Lozach P, Menez JF, Berthou F (1996) Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes. Carcinogenesis 17, 2029-34.
23. Pennan BW, Reece J, Smith TY, Gelboin HV, Gonzalez FJ, Crespi CL (1993) Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6. Pharmacogenetics 3, 28-39.
24. Anwar WA, Abdel-Rahman SZ, Ei-Zein RA, Mostata HM, Au WW (1996) Genetic polymorphism of GSTM1, CYP2E1, and CYP2D6 in Egyptian bladder cancer patient. Carcinogenesis 17, 1923-9.
25. Wolf CR, Smith CAD, Gough AC, Moss JE, Vallis KA, Howard G, Carey FJ, Mills K, McNee W, Carmichael J, Spurr NK (1992) Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis 13, 1035-8.
26. Bouchardy C, Benhamou S, Dayer P (1996) The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res. 56, 251-3.
27. Harada S (1990) Isozymes, structure, function, and use in biology and medicine. 289-294, Wiley-Lis.
28. Tanaka F, Shiratori Y, Yokosuka O, Imazeki F, Tsukada Y, Omata M (1997) Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcoholism: Clin Exp Res 21, 596-601.
29. Chasseaud LF (1979) The role of glutathione and glutathione S-transferase in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 29, 175-274.
30. Mannervik B, Alin P, Guthenberg C, Jensson H, Tahir MK, Warholm M, Jornall H (1985) Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 82, 7202-6.
31. Mannervik B, Awasthi YC, Board PG, Hayes JD, Di Ilio C, Ketterer B, Listowsky I, Morgenstern R, Muramatsu M, Pearson WR, Pickett CB, Sato K, Widersten M, Wolf CR (1992) Nomenclature for human glutathione transferase. Biochem J 282, 305-8.
32. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie J (1990) Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer. Carcinogenesis 11, 33-6.
33. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, Leng Z-T, Stapleton P, Weiss NS (1993) The glutathione S-transferase u polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53, 2313-8.
34. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Vainio H (1993) The GSTM1 null genotypes as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis 14, 1479-81.
35. Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A, Lear JT, Heagerty AH, Bowers B, Hand P, Hayes JD, Jones PW, Strange RC, Feyer AA (1996) Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 56, 1974-7.
36. Jourenkova-Mironova N, Voho A, Bouchardy C, Wikman H, Dayer P, Benhamou S, Hirbonen A (1999) Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk. Cancer Epidem Biomark Prev 8, 185-8.
37. Jahnke V, Matthias C, Fryer A, Strange R (1996) Glutathione S-transferase and cytochrome P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am J Surgery 172, 671-3.
38. Wiencke JK, Pemble S, Ketterer B, Keley KT (1995) Gene deletion of glutathione transferase theta 1: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomarkers Prev 4, 253-60.
39. Pemble S, Schroeder K, Spencer S (1994) Human glutathione s-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300, 271-6.
40. Chen H, Sandier DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA (1996) Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GASTT1) gene defect. Lancet 347, 295-7.
41. Jourenkova-Mironova N, Voho A, Bouchardy C, Wikman H, Dayer P, Benhamou S, Hirbonen A (1999) Glutathione S-transferase GSTM1, GSTM3, GSTP1, and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 81, 44-8.
42. Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Matsumoto T, Kawamoto T, Bell DA (1999) Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal, and urothelial cancer. Pharmacogenetics 9, 165-9.
43. To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Carrasco JI, Ramon J. Corbella J (1999) Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes Cont 10, 65-70.
44. Harada S, Abai M, Tanaka N, Agarwal D, Goedde HW (1987) Liver glutathione S-transferase polymorphism in Japanese subjects and its pharmacogenetic importance. Hum Genet 75, 322-5.
45. Board PG (1981) Biochemical genetics of glutathione S-transferase in man. Am J Hum Genet 33, 36-43.
46. Ketterer B, Meyer DJ, Clark AG (1988) Soluble glutathione transferase isoenzymes. In: Glutathione conjugation: Mechanisms and biological significance. eds. by Sies H, Ketterer B, Academic Press New York.
47. Nielsen PS, Okkels H, Sigsgaard T, Kyrtopoulos S, Autrup H (1996) Exposure to urban and rural air pollution: DNA and protein adducts and effect of glutathione S-transferase genotype on adduct levels. Int Arch Occup Environ Health 68, 170-6.
48. Sorsa M, Osterman-Golkar S, Peltonen K, Saarikoski ST, Sram R (1996) Assessment of exposure to butadiene in the process industry. Toxicology 113, 77-83.
49. Kadlubar FF (1994) Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans. Drug Met Rev 26, 37-46.
50. Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF (1995) Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 55, 5230-7.
51. Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamine N-acetyltransferase acetyltransferase gene: isolation, chromosomal location, and functional expression. DNA Cell Biol 9, 193-203.
52. Risch A, Wallace DMA, Bathers S, Sim E (1995) Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 4, 231-6.
53. Knudsen LE, Norppa H, Gamborg MO, Nielsen PS, Okkels H, Soll-Johanning H, Raffn E, Jarventaus H, Autrup H (1999) Chromosomal aberrations in humans induced by urban air pollution: incidence of DNA repair and polymorphism of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidem Biomark Prev 8, 303-10.
54. Koizumi A, Nomiyama T, Tsukada M, Wada Y, Omae K, Tanaka S, Miyauchi H, Imamiya S, Sakurai H (1998) Evidence of N-acetyltransferase allele-associated metabolism of hydrazine in Japanese workers. J Occup Environ Med 40, 217-22.
55. Nomiyama T, Omae K, Tanaka S, Miyauchi H, Koizumi A, Tsukada M, Wada Y, Mori T, Imamiya S, Sakurai H (1998) A cross-sectional observation of the health effects of hydrazine hydrate and differences of its metabolism by NAT2 polymorphism. Int Arch Occup Environ Health 71 (Suppl), S33-6.
56. Nakajima T, Koyama Y, Sato A (1982) Dietary modification of metabolism and toxicity of chemical substances -with special reference to carbohydrates. Biochem Pharmacol 31, 1005-11.
57. Nakajima T, Sato A (1979) Enhanced activity of liver drug-metabolizing enzymes for aromatic and chlorinated hydrocarbons following food deprivation. Toxicol Appl Pharmacol 50, 549-56.
58. Sato A, Nakajima T, Koyama Y (1980) Effects of chronic ethanol consumption on hepatic metabolism of aromatic and chlorinated hydrocarbons in rats. Br J Ind Med 37, 382-6.
59. Sato A, Nakajima T (1985) Enhanced metabolism of volatile hydrocarbons in rat liver following food deprivation, restricted carbohydrate intake, and administration of ethanol, phenobarbital, polychlorinated biphenyl, and 3-methylcholanthrene: a comparative study. Xenobiotica 15, 67-75.
60. Nakajima T, Elovaara E, Okino T, Gelboin HV, Klockars M, Riihimaki V, Aoyama T, Vainio H (1995) Different contribution of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat. Toxicol Appl Pharmacol 133, 215-22.
61. Nakajima T, Okino T, Okuyama S, Kaneko T, Yonekura Y, Sato A (1988) Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: differences from the effect of phenobarbital. Toxicol Appl Pharmacol 94, 227-37.
62. Nakajima T, Wang RS, Katakura Y, Kishi R, Elovaara E, Park SS, Gelboin HV, Vainio H (1992) Sex-, age-, and pregnancy-induced changes in the metabolism of toluene and trichloroethylene in rat liver in relation to the regulation of cytochrome P450IIE1 and P450IIC11 content. J Pharmacol Exp Ther 261, 869-74.
63. Dong ZG, Hong JY, Ma QA, Li DC, Bullock J, Gonzalez FJ, Park SS, Gelboin HV, Yang CS (1988) Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. Arch Biochem Biophys 263, 29-35.
64. Stewart RD, Hake CL, Peterson JE (1974) "Degreasers' flush". Dermal response to trichloroethylene and ethanol. Arch Environ Health 29, 1-5.
65. Wang RS, Nakajima T, Honma T (1999) Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rat. Toxicology 132, 9-18.
66. Petruzzelli S, Camus A-M, Carrozzi L, Ghelarducci L, Rindi M, Menconi C, Angeletti CA, Ahotupa M, Hietanen E, Aitio A, Saracci R, Bartsch H, Giuntini C (1988) Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes; a case control study on lung cancer patients. Cancer Res 48, 4695-700.
67. Anttila S, Hietanen E, Vainio H, Camus A-M, Gelboin HV, Park SS, Heikkila L, Karjalainen, A, Bartsch H (1991) Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int J Cancer 47, 681-5.